Kaitlin Anstett, PhD

Director, Medical Affairs
Theratechnologies Inc., Canada

Poster(s):

• (A-124) Evaluating effectiveness of ibalizumab among highly treatment experienced people with HIV: an externally controlled trial
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET